Dr. Yana Najjar

Yana G. Najjar, MD is a translational investigator and cutaneous oncologist at UPMC Hillman Cancer Center, where she also is an associate professor of medicine and Director of the Clinical and Translational Research Center. Dr. Najjar specializes in early phase clinical trials and in the treatment of advanced melanoma. Her research focusing on immunotherapy resistant melanoma and rare melanoma subtypes. She has developed multiple investigator-initiated trials that aim to remodel melanoma tumor cell metabolism and hypoxia in the tumor microenvironment to overcome mechanisms of resistance to immunotherapy. Her lab is focused on various correlative analyses from investigator-initiated trials. Dr. Najjar's research is funded by the NIH, the Department of Defense, and the Melanoma Research Alliance.

Dr. Najjar is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Melanoma of the Eye, Renal Cell Carcinoma (RCC), and Gamma Knife Radiosurgery.

Dr. Najjar is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 54 peer reviewed articles and participating in 3 clinical trials. Dr. Najjar is currently accepting new patients.